BSD-2000 3D/MR Commercialization
Deep-seated Tumors (multiple cancer types)
Key Facts
About Pyrexar Medical
Pyrexar Medical, founded in 2008 and headquartered in Salt Lake City, Utah, is a private company commercializing hyperthermia therapy devices for oncology. Its core technology uses phased-array RF antennas to deliver localized, image-guided heat to tumors, a modality supported by Level 1 clinical evidence for several cancer types. While the company generates revenue from sales of certain systems internationally, its advanced BSD-2000 3D/MR platform, which integrates real-time MR thermometry, is not yet available in the U.S. market, representing a significant regulatory and commercial hurdle. Pyrexar's strategy is to position hyperthermia as a synergistic, low-toxicity adjunct to standard cancer care.
View full company profile